Indian scientists have developed an experimental anti-cancer drug, dubbed “RK-251,” that is activated primarily inside cancer cells. The Ministry of Science and Technology announced the breakthrough, suggesting the drug could become a potential alternative to traditional chemotherapy. Testing on zebrafish embryos showed no significant signs of toxicity, according to a ministry press release. Further research is underway to fully understand the drug’s efficacy and potential side effects in humans. This development offers a hopeful new avenue in the fight against cancer. The drug targets cancerous cells specifically, potentially minimizing harm to healthy tissue, a common challenge with current treatments. This innovative approach underscores advancements in Indian pharmaceutical research.